Accretive Wealth Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $348K | Hold |
5,045
| – | – | 0.11% | 118 |
|
|
2025
Q1 | $334K | Sell |
5,045
-1,000
| -17% | -$66.3K | 0.12% | 122 |
|
|
2024
Q4 | $520K | Hold |
6,045
| – | – | 0.22% | 102 |
|
|
2024
Q3 | $720K | Sell |
6,045
-105
| -2% | -$12.5K | 0.3% | 97 |
|
|
2024
Q2 | $878K | Hold |
6,150
| – | – | 0.37% | 87 |
|
|
2024
Q1 | $757K | Hold |
6,150
| – | – | 0.33% | 92 |
|
|
2023
Q4 | $636K | Hold |
6,150
| – | – | 0.31% | 98 |
|
|
2023
Q3 | $559K | Hold |
6,150
| – | – | 0.33% | 87 |
|
|
2023
Q2 | $498K | Hold |
6,150
| – | – | 0.3% | 90 |
|
|
2023
Q1 | $489K | Hold |
6,150
| – | – | 0.31% | 91 |
|
|
2022
Q4 | $416K | Buy |
+6,150
| New | +$416K | 0.29% | 89 |
|